Navigation Links
Pre-Owned Prices on Premium Pharmaceutical Equipment
Date:8/18/2009

CANTON, Mass., Aug. 18 /PRNewswire/ -- Small and large companies around the world realize the importance of cutting costs to stay profitable in this economy. EquipNet is announcing an amazing opportunity for pharmaceutical companies to get great deals on processing and packaging equipment from a leading pharmaceutical manufacturer. A webcast auction of premium, pre-owned equipment has been scheduled for Thursday, August 27 at 11am. Enthusiastic bargain hunters can make pre-sale purchases now at www.EquipNet.com.

EquipNet, the world's leading provider of surplus asset management sales and service, has been selected to sell this equipment that is sitting idle in the company's Puerto Rico facility.

"Buyers and sellers both win with a project like this auction," explains Carl Cote, EquipNet's Vice President of Pharmaceutical Sales. "Buyers get a bargain on some nice equipment from an industry leader and the seller generates revenue by clearing out surplus equipment that's just taking up space."

This project allows companies to buy pre-owned equipment for less than they would have to pay for mid-range new items. This auction lot includes terrific finds for local and global manufacturers looking to replace or add equipment at their facilities. Listings include: Fluid Bed Dryers; Tablet and Capsule Filling Lines, Tablet Presses, Autoclaves, Blenders, and more.

Specifications and photos for all the auction items can be found at www.EquipNet.com/AugWebcast. All equipment is currently located in Puerto Rico.

About EquipNet

EquipNet is a leading provider of proactive asset management solutions and services to leading corporations in the pharmaceutical, biotech, chemical, and consumer packaged goods industries, such as Merck, GlaxoSmithKline, AstraZeneca, Unilever and many others. EquipNet's vision is to revolutionize the way companies manage their surplus assets by maximizing financial returns and minimizing the risks associated with idle capital assets. For more information, please visit: http://www.EquipNet.com.

    Contact: Ben Potenza
    EquipNet Marketing
    Phone: (781) 821-3482, x2180


'/>"/>
SOURCE EquipNet
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
2. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
3. Beckman Coulter Prices $500 Million Senior Notes Offering
4. DNA Heritage Success in Patent Battle Helps Keep Genealogy DNA Test Prices Low
5. BioMed Realty Trust Prices Public Offering of 5,700,000 Shares of Common Stock
6. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
7. NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock
8. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
9. Massive Inventory of Premium Lab & Analytical Equipment Now Available
10. AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to Consumers
11. Natures Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):